Hikal Ltd
NSE:HIKAL

Watchlist Manager
Hikal Ltd Logo
Hikal Ltd
NSE:HIKAL
Watchlist
Price: 373.85 INR 2.06% Market Closed
Market Cap: 46.1B INR
Have any thoughts about
Hikal Ltd?
Write Note

Hikal Ltd
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hikal Ltd
Long-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Hikal Ltd
NSE:HIKAL
Long-Term Investments
â‚ą213.3m
CAGR 3-Years
10%
CAGR 5-Years
75%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Long-Term Investments
â‚ą7.1B
CAGR 3-Years
-5%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Long-Term Investments
â‚ą12.2B
CAGR 3-Years
34%
CAGR 5-Years
17%
CAGR 10-Years
13%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Long-Term Investments
â‚ą68.1B
CAGR 3-Years
2%
CAGR 5-Years
7%
CAGR 10-Years
23%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Long-Term Investments
â‚ą650m
CAGR 3-Years
-14%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
M
Mankind Pharma Ltd
NSE:MANKIND
Long-Term Investments
â‚ą3.2B
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Hikal Ltd
Glance View

Market Cap
46.1B INR
Industry
Pharmaceuticals

Hikal Ltd. engages in the manufacture of chemical intermediates, specialty chemicals, active pharma ingredients, and contract research activities. The company is headquartered in Navi Mumbai, Maharashtra. The Company’s operating segments include the crop protection and pharmaceuticals space. The Crop protection produce and trades in pesticides and herbicides. Its facilities are in Taloja, Mahad (Maharashtra), and Panoli (Gujarat). The Pharmaceuticals space produce and trades in active pharmaceuticals ingredients. Its facilities are in Jigani (Bengaluru) and Panoli (Gujarat). The Company’s products and services include gabapentin, thiabendazole, and diuron contract development and custom manufacturing of intermediates, application programming interface (APIs), and artificial intelligence (AI’s). The company offers solutions to route scouting, process development, analytical method development, technology development, process engineering, scale-up support, and small-scale synthesis.

HIKAL Intrinsic Value
268.95 INR
Overvaluation 28%
Intrinsic Value
Price

See Also

What is Hikal Ltd's Long-Term Investments?
Long-Term Investments
213.3m INR

Based on the financial report for Sep 30, 2024, Hikal Ltd's Long-Term Investments amounts to 213.3m INR.

What is Hikal Ltd's Long-Term Investments growth rate?
Long-Term Investments CAGR 5Y
75%

Over the last year, the Long-Term Investments growth was -1%. The average annual Long-Term Investments growth rates for Hikal Ltd have been 10% over the past three years , 75% over the past five years .

Back to Top